CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study).

The aim of this study was to test the hypothesis of Goldie and Coldman that the use of non-cross-resistant regimens of chemotherapy could lead to maximal anti-tumour effect. We compared standard CMF (cyclophosphamide, methotrexate, fluorouracil) with alternating CMF/EV (epirubicin, vincristine) in t...

Descripción completa

Detalles Bibliográficos
Autores principales: De Placido, S., Perrone, F., Carlomagno, C., Morabito, A., Pagliarulo, C., Lauria, R., Marinelli, A., De Laurentiis, M., Varriale, E., Petrella, G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033842/
https://www.ncbi.nlm.nih.gov/pubmed/7779724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033842/
https://www.ncbi.nlm.nih.gov/pubmed/7779724

Ejemplares similares